去肾交感神经治疗顽固性高血压的当前适应证
马为,霍勇
摘要(Abstract)：
<正>近年来,伴随着肥胖、高盐、高脂饮食的流行,我国高血压的发病率逐年增高,目前估计高血压患病人数已超过2亿。高血压是心脑血管疾病的重要危险因素之一,严重威胁人类健康,是我国最主要的疾病负担之一,估计有40%~50%的心肌梗死,50%~75%的脑卒中归因于高血压,直接造成的经济费用每年约366亿,导致200万人过早死亡。尽管近年来高血压的药物治疗取得了令人瞩目的成就,在降低血压和心血管事件方面发挥了重要作用,
关键词(KeyWords)：
基金项目(Foundation): 北京大学-清华大学生命联合中心资助
作者(Author): 马为,霍勇
参考文献(References)：
- [1]Calhoun DA,Jones D,Textor S,et al.Resistant hypertension:diagnosis,evaluation,and treatment.A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research[J].Hypertension,2008,51(6):1403-1419.
- [2]Krum H,Schlaich M,Whitbourn R,et al.Catheter-based renal sympathetic denervation for resistant hypertension:a multicentre safety and proof-of-principle cohort study[J].Lancet,2009,373(9671):1275-1281.
- [3]Simplicity HTN-2 Investigators,Esler MD,Krum H,et al.Renal sympathetic denervation in patients with treatment-resistant hypertension(The Symplicity HTN-2 Trial):a randomised controlled trial[J].Lancet,2010,376(9756):1903-1909.
- [4]Schmieder RE,Redon J,Grassi G,et al.ESH position paper:renal denervation-an interventional therapy of resistant hypertension[J].J Hypertens,2012,30(5):837-841.
- [5]Mahfoud F,Lüscher TF,Andersson B,et al.Expert consensus document from the European Society of Cardiology on catheter-based renal denervation[J].Eur Heart J,2013,34(28):2149-2157.